Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics

Gliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI morphological characteristics, apparent diffusion coefficient (ADC) parameters and pathological grades, as well as IDH gene phenotypes of gliomas.Background and PurposeGli...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 873839
Main Authors Du, Ningfang, Zhou, Xiaotao, Mao, Renling, Shu, Weiquan, Xiao, Li, Ye, Yao, Xu, Xinxin, Shen, Yilang, Lin, Guangwu, Fang, Xuhao, Li, Shihong
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 27.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Gliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI morphological characteristics, apparent diffusion coefficient (ADC) parameters and pathological grades, as well as IDH gene phenotypes of gliomas.Background and PurposeGliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI morphological characteristics, apparent diffusion coefficient (ADC) parameters and pathological grades, as well as IDH gene phenotypes of gliomas.Preoperative MRI data from 166 glioma patients with pathological confirmation were retrospectively analyzed to compare the differences of MRI characteristics and ADC parameters between the low-grade and high-grade gliomas (LGGs vs. HGGs), IDH mutant and wild-type gliomas (IDHmut vs. IDHwt). Multivariate models were constructed to predict the pathological grades and IDH gene phenotypes of gliomas and the performance was assessed by the receiver operating characteristic (ROC) analysis.MethodsPreoperative MRI data from 166 glioma patients with pathological confirmation were retrospectively analyzed to compare the differences of MRI characteristics and ADC parameters between the low-grade and high-grade gliomas (LGGs vs. HGGs), IDH mutant and wild-type gliomas (IDHmut vs. IDHwt). Multivariate models were constructed to predict the pathological grades and IDH gene phenotypes of gliomas and the performance was assessed by the receiver operating characteristic (ROC) analysis.Two multivariable logistic regression models were developed by incorporating age, ADC parameters, and MRI morphological characteristics to predict pathological grades, and IDH gene phenotypes of gliomas, respectively. The Noninvasive Grading Model classified tumor grades with areas under the ROC curve (AUROC) of 0.934 (95% CI=0.895-0.973), sensitivity of 91.2%, and specificity of 78.6%. The Noninvasive IDH Genotyping Model differentiated IDH types with an AUROC of 0.857 (95% CI=0.787-0.926), sensitivity of 88.2%, and specificity of 63.8%.ResultsTwo multivariable logistic regression models were developed by incorporating age, ADC parameters, and MRI morphological characteristics to predict pathological grades, and IDH gene phenotypes of gliomas, respectively. The Noninvasive Grading Model classified tumor grades with areas under the ROC curve (AUROC) of 0.934 (95% CI=0.895-0.973), sensitivity of 91.2%, and specificity of 78.6%. The Noninvasive IDH Genotyping Model differentiated IDH types with an AUROC of 0.857 (95% CI=0.787-0.926), sensitivity of 88.2%, and specificity of 63.8%.MRI features were correlated with glioma grades and IDH mutation status. Multivariable logistic regression models combined with MRI morphological characteristics and ADC parameters may provide a noninvasive and preoperative approach to predict glioma grades and IDH mutation status.ConclusionMRI features were correlated with glioma grades and IDH mutation status. Multivariable logistic regression models combined with MRI morphological characteristics and ADC parameters may provide a noninvasive and preoperative approach to predict glioma grades and IDH mutation status.
AbstractList Background and PurposeGliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI morphological characteristics, apparent diffusion coefficient (ADC) parameters and pathological grades, as well as IDH gene phenotypes of gliomas.MethodsPreoperative MRI data from 166 glioma patients with pathological confirmation were retrospectively analyzed to compare the differences of MRI characteristics and ADC parameters between the low-grade and high-grade gliomas (LGGs vs. HGGs), IDH mutant and wild-type gliomas (IDHmut vs. IDHwt). Multivariate models were constructed to predict the pathological grades and IDH gene phenotypes of gliomas and the performance was assessed by the receiver operating characteristic (ROC) analysis.ResultsTwo multivariable logistic regression models were developed by incorporating age, ADC parameters, and MRI morphological characteristics to predict pathological grades, and IDH gene phenotypes of gliomas, respectively. The Noninvasive Grading Model classified tumor grades with areas under the ROC curve (AUROC) of 0.934 (95% CI=0.895-0.973), sensitivity of 91.2%, and specificity of 78.6%. The Noninvasive IDH Genotyping Model differentiated IDH types with an AUROC of 0.857 (95% CI=0.787-0.926), sensitivity of 88.2%, and specificity of 63.8%.ConclusionMRI features were correlated with glioma grades and IDH mutation status. Multivariable logistic regression models combined with MRI morphological characteristics and ADC parameters may provide a noninvasive and preoperative approach to predict glioma grades and IDH mutation status.
Gliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI morphological characteristics, apparent diffusion coefficient (ADC) parameters and pathological grades, as well as IDH gene phenotypes of gliomas.Background and PurposeGliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI morphological characteristics, apparent diffusion coefficient (ADC) parameters and pathological grades, as well as IDH gene phenotypes of gliomas.Preoperative MRI data from 166 glioma patients with pathological confirmation were retrospectively analyzed to compare the differences of MRI characteristics and ADC parameters between the low-grade and high-grade gliomas (LGGs vs. HGGs), IDH mutant and wild-type gliomas (IDHmut vs. IDHwt). Multivariate models were constructed to predict the pathological grades and IDH gene phenotypes of gliomas and the performance was assessed by the receiver operating characteristic (ROC) analysis.MethodsPreoperative MRI data from 166 glioma patients with pathological confirmation were retrospectively analyzed to compare the differences of MRI characteristics and ADC parameters between the low-grade and high-grade gliomas (LGGs vs. HGGs), IDH mutant and wild-type gliomas (IDHmut vs. IDHwt). Multivariate models were constructed to predict the pathological grades and IDH gene phenotypes of gliomas and the performance was assessed by the receiver operating characteristic (ROC) analysis.Two multivariable logistic regression models were developed by incorporating age, ADC parameters, and MRI morphological characteristics to predict pathological grades, and IDH gene phenotypes of gliomas, respectively. The Noninvasive Grading Model classified tumor grades with areas under the ROC curve (AUROC) of 0.934 (95% CI=0.895-0.973), sensitivity of 91.2%, and specificity of 78.6%. The Noninvasive IDH Genotyping Model differentiated IDH types with an AUROC of 0.857 (95% CI=0.787-0.926), sensitivity of 88.2%, and specificity of 63.8%.ResultsTwo multivariable logistic regression models were developed by incorporating age, ADC parameters, and MRI morphological characteristics to predict pathological grades, and IDH gene phenotypes of gliomas, respectively. The Noninvasive Grading Model classified tumor grades with areas under the ROC curve (AUROC) of 0.934 (95% CI=0.895-0.973), sensitivity of 91.2%, and specificity of 78.6%. The Noninvasive IDH Genotyping Model differentiated IDH types with an AUROC of 0.857 (95% CI=0.787-0.926), sensitivity of 88.2%, and specificity of 63.8%.MRI features were correlated with glioma grades and IDH mutation status. Multivariable logistic regression models combined with MRI morphological characteristics and ADC parameters may provide a noninvasive and preoperative approach to predict glioma grades and IDH mutation status.ConclusionMRI features were correlated with glioma grades and IDH mutation status. Multivariable logistic regression models combined with MRI morphological characteristics and ADC parameters may provide a noninvasive and preoperative approach to predict glioma grades and IDH mutation status.
Author Du, Ningfang
Zhou, Xiaotao
Li, Shihong
Mao, Renling
Shu, Weiquan
Ye, Yao
Xu, Xinxin
Shen, Yilang
Lin, Guangwu
Fang, Xuhao
Xiao, Li
AuthorAffiliation 3 Department of Neurosurgery, Huadong Hospital, Fudan University , Shanghai , China
4 Department of Pathology, Huadong Hospital, Fudan University , Shanghai , China
2 Department of Emergency, Changhai Hospital, Naval Medical University, Second Military Medical University , Shanghai , China
5 Clinical Research Center for Gerontology, Huadong Hospital, Fudan University , Shanghai , China
6 Institute of Business Analytics, Adelphi University , Garden City, NY , United States
1 Department of Radiology, Huadong Hospital, Fudan University , Shanghai , China
AuthorAffiliation_xml – name: 4 Department of Pathology, Huadong Hospital, Fudan University , Shanghai , China
– name: 5 Clinical Research Center for Gerontology, Huadong Hospital, Fudan University , Shanghai , China
– name: 3 Department of Neurosurgery, Huadong Hospital, Fudan University , Shanghai , China
– name: 6 Institute of Business Analytics, Adelphi University , Garden City, NY , United States
– name: 1 Department of Radiology, Huadong Hospital, Fudan University , Shanghai , China
– name: 2 Department of Emergency, Changhai Hospital, Naval Medical University, Second Military Medical University , Shanghai , China
Author_xml – sequence: 1
  givenname: Ningfang
  surname: Du
  fullname: Du, Ningfang
– sequence: 2
  givenname: Xiaotao
  surname: Zhou
  fullname: Zhou, Xiaotao
– sequence: 3
  givenname: Renling
  surname: Mao
  fullname: Mao, Renling
– sequence: 4
  givenname: Weiquan
  surname: Shu
  fullname: Shu, Weiquan
– sequence: 5
  givenname: Li
  surname: Xiao
  fullname: Xiao, Li
– sequence: 6
  givenname: Yao
  surname: Ye
  fullname: Ye, Yao
– sequence: 7
  givenname: Xinxin
  surname: Xu
  fullname: Xu, Xinxin
– sequence: 8
  givenname: Yilang
  surname: Shen
  fullname: Shen, Yilang
– sequence: 9
  givenname: Guangwu
  surname: Lin
  fullname: Lin, Guangwu
– sequence: 10
  givenname: Xuhao
  surname: Fang
  fullname: Fang, Xuhao
– sequence: 11
  givenname: Shihong
  surname: Li
  fullname: Li, Shihong
BookMark eNp1kstuEzEUhkeoiJbSPUsv2SR4fJnLBgmFkkRqAKFWYmedsc8krhx7sCeR-gI8N56mQhQJb-xz-T8fy__r4swHj0XxtqRzzpv2fR-8njPK2LypecPbF8UFY1zMWsF_nP11Pi-uUrqneVWSlpS_Ks65rEsmGn5R_PoWMQwYYbRHJOAN-RK89UdIU5yLxurRBk9CT5bOhj0ksrJpDAOMu-DC1mpwZBnBYHqUrz-tyCY41AcHkdw-DDl_l6zfks3BjXZwSDbf12Sxgwh6xJhZVqc3xcseXMKrp_2yuPt8fbtYzW6-LteLjzczLXg7zoTWJeOy12CEZNhoKXUt-77quJaGMSq0kLpB0desM43hKGvocl_bIytrwy-L9YlrAtyrIdo9xAcVwKrHRIhbBTEP5FDJCmUmtqLVtQCsG2ipNLzpaNejkHVmfTixhkO3R6PRjxHcM-jzirc7tQ1H1ZZtxcQEePcEiOHnAdOo9jZpdA48hkNSrKobkZ9LRW6lp1YdQ0oR-z_XlFRNblCTG9TkBnVyQ5ZU_0i0HWH6yzyMdf8X_gY3Gb6F
CitedBy_id crossref_primary_10_1007_s00330_024_11140_5
crossref_primary_10_3390_biomedicines10102490
crossref_primary_10_1186_s12967_023_03950_w
crossref_primary_10_3390_cancers15020482
crossref_primary_10_3390_cancers16040681
crossref_primary_10_1186_s40644_024_00726_3
crossref_primary_10_3390_cancers16081543
crossref_primary_10_1007_s00234_023_03145_6
crossref_primary_10_1007_s11060_024_04609_2
crossref_primary_10_1590_0100_3984_2024_0025
crossref_primary_10_1109_JBHI_2023_3279433
Cites_doi 10.1007/s11060-017-2506-9
10.1093/neuonc/noab106
10.3174/ajnr.A5171
10.1007/s00401-018-1905-0
10.2214/ajr.17.18457
10.1371/journal.pone.0142750
10.1371/journal.pone.0079008
10.1158/0008-5472.Can-14-2893
10.3389/fnagi.2017.00432
10.1007/s11060-015-1909-8
10.3174/ajnr.A5650
10.1007/s11060-020-03662-x
10.1007/s11060-018-03034-6
10.1148/radiol.2020191832
10.1002/14651858.CD009319.pub3
10.1158/1078-0432.Ccr-17-0560
10.3171/2012.11.Jns121100
10.1093/neuonc/not015
10.1159/000464439
10.1016/j.crad.2019.01.028
10.1093/neuonc/now256
10.1093/neuonc/noy048
10.1016/j.jocn.2017.01.007
10.1007/s00234-020-02532-7
10.13929/J.1003-3289.201901063
10.1007/s00330-019-06395-2
10.1016/j.wneu.2020.05.278
10.1111/bpa.12171
10.1007/s00401-010-0725-7
10.2174/1573405615666190109100503
10.1007/s00401-016-1545-1
10.1158/1078-0432.Ccr-09-0715
10.1038/ncponc1073
10.1007/s11060-016-2313-8
10.1056/NEJMoa1407279
10.1007/s12094-017-1631-4
10.1016/j.jns.2016.12.008
10.1016/j.ejrad.2017.08.008
10.1016/j.nec.2018.08.008
10.13609/j.cnki.1000-0313.2021.07.003
10.1016/j.semcancer.2017.11.010
ContentType Journal Article
Copyright Copyright © 2022 Du, Zhou, Mao, Shu, Xiao, Ye, Xu, Shen, Lin, Fang and Li.
Copyright © 2022 Du, Zhou, Mao, Shu, Xiao, Ye, Xu, Shen, Lin, Fang and Li 2022 Du, Zhou, Mao, Shu, Xiao, Ye, Xu, Shen, Lin, Fang and Li
Copyright_xml – notice: Copyright © 2022 Du, Zhou, Mao, Shu, Xiao, Ye, Xu, Shen, Lin, Fang and Li.
– notice: Copyright © 2022 Du, Zhou, Mao, Shu, Xiao, Ye, Xu, Shen, Lin, Fang and Li 2022 Du, Zhou, Mao, Shu, Xiao, Ye, Xu, Shen, Lin, Fang and Li
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fonc.2022.873839
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
ExternalDocumentID oai_doaj_org_article_56e5220949c74ae78a905d38b0bfe457
PMC9196247
10_3389_fonc_2022_873839
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c439t-4cc1235fcad452e8c55c75ff6b3c5d2204c45c8e4f72bd8d3e57abe8c9fe217d3
IEDL.DBID M48
ISSN 2234-943X
IngestDate Wed Aug 27 01:21:32 EDT 2025
Thu Aug 21 18:19:25 EDT 2025
Fri Jul 11 15:17:33 EDT 2025
Tue Jul 01 00:47:27 EDT 2025
Thu Apr 24 22:51:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-4cc1235fcad452e8c55c75ff6b3c5d2204c45c8e4f72bd8d3e57abe8c9fe217d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Cancer Imaging and Image-directed Interventions, a section of the journal Frontiers in Oncology
These authors have contributed equally to this work
Reviewed by: Oliver Geier, Oslo University Hospital, Norway; Morteza Esmaeili, Akershus University Hospital, Norway; Jonn Geitung, University of Oslo, Norway
Edited by: Tone Frost Bathen, Norwegian University of Science and Technology, Norway
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fonc.2022.873839
PMID 35712483
PQID 2678423504
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_56e5220949c74ae78a905d38b0bfe457
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9196247
proquest_miscellaneous_2678423504
crossref_primary_10_3389_fonc_2022_873839
crossref_citationtrail_10_3389_fonc_2022_873839
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-05-27
PublicationDateYYYYMMDD 2022-05-27
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-27
  day: 27
PublicationDecade 2020
PublicationTitle Frontiers in oncology
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Wang (B1) 2019; 30
Nakae (B37) 2017; 131
van den Bent (B27) 2010; 120
Villanueva-Meyer (B15) 2018; 210
Eckel-Passow (B4) 2015; 372
Louis (B7) 2016; 131
Gusyatiner (B2) 2018; 51
Delgado-López (B10) 2017; 19
Broen (B18) 2018; 20
Gozé (B38) 2013; 118
Louis (B8) 2021; 23
Xing (B22) 2017; 38
Nobusawa (B9) 2009; 15
Patterson (B20) 2008; 5
Cahill (B28) 2015; 125
Lee (B12) 2020; 30
Nakae (B26) 2015; 10
Agarwal (B24) 2013; 15
Oltra-Sastre (B31) 2019; 15
Lasocki (B35) 2017; 39
Zhang (B13) 2017; 373
Leu (B21) 2017; 134
Jiang (B29) 2017; 4
Korfiatis (B32) 2019; 74
Zhou (B34) 2017; 19
Alkanhal (B36) 2020; 141
Lasocki (B3) 2021; 63
Maynard (B11) 2020; 296
Hempel (B23) 2017; 95
Louis (B6) 2014; 24
Zhang (B33) 2021; 36
Juratli (B14) 2019; 141
Song (B16) 2019; 35
White (B19) 2014; 74
Cao (B41) 2017; 9
Patel (B17) 2017; 23
Poetsch (B25) 2021; 151
Chen (B39) 2013; 8
Patel (B30) 2018; 30
Stichel (B5) 2018; 136
Suh (B40) 2018; 39
References_xml – volume: 134
  year: 2017
  ident: B21
  article-title: Perfusion and Diffusion MRI Signatures in Histologic and Genetic Subtypes of WHO Grade II-III Diffuse Gliomas
  publication-title: J Neurooncol
  doi: 10.1007/s11060-017-2506-9
– volume: 23
  year: 2021
  ident: B8
  article-title: The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/noab106
– volume: 38
  year: 2017
  ident: B22
  article-title: Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined With Conventional MR Imaging
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A5171
– volume: 136
  start-page: 793
  year: 2018
  ident: B5
  article-title: Distribution of EGFR Amplification, Combined Chromosome 7 Gain and Chromosome 10 Loss, and TERT Promoter Mutation in Brain Tumors and Their Potential for the Reclassification of IDHwt Astrocytoma to Glioblastoma
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-018-1905-0
– volume: 210
  year: 2018
  ident: B15
  article-title: MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.17.18457
– volume: 10
  year: 2015
  ident: B26
  article-title: PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas
  publication-title: PloS One
  doi: 10.1371/journal.pone.0142750
– volume: 8
  year: 2013
  ident: B39
  article-title: The Correlation Between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis
  publication-title: PloS One
  doi: 10.1371/journal.pone.0079008
– volume: 74
  start-page: 6733
  year: 2014
  ident: B19
  article-title: Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.Can-14-2893
– volume: 9
  year: 2017
  ident: B41
  article-title: Application of a Simplified Method for Estimating Perfusion Derived From Diffusion-Weighted MR Imaging in Glioma Grading
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2017.00432
– volume: 125
  year: 2015
  ident: B28
  article-title: The Role of Neuropathology in the Management of Patients With Diffuse Low Grade Glioma: A Systematic Review and Evidence-Based Clinical Practice Guideline
  publication-title: J Neurooncol
  doi: 10.1007/s11060-015-1909-8
– volume: 39
  year: 2018
  ident: B40
  article-title: Diffusion-Weighted Imaging and Diffusion Tensor Imaging for Differentiating High-Grade Glioma From Solitary Brain Metastasis: A Systematic Review and Meta-Analysis
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A5650
– volume: 151
  year: 2021
  ident: B25
  article-title: Characteristics of IDH-Mutant Gliomas With Non-Canonical IDH Mutation
  publication-title: J Neurooncol
  doi: 10.1007/s11060-020-03662-x
– volume: 141
  year: 2019
  ident: B14
  article-title: Radiographic Assessment of Contrast Enhancement and T2/FLAIR Mismatch Sign in Lower Grade Gliomas: Correlation With Molecular Groups
  publication-title: J Neurooncol
  doi: 10.1007/s11060-018-03034-6
– volume: 296
  year: 2020
  ident: B11
  article-title: World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient
  publication-title: Radiology
  doi: 10.1148/radiol.2020191832
– volume: 4
  start-page: Cd009319
  year: 2017
  ident: B29
  article-title: Biopsy Versus Resection for the Management of Low-Grade Gliomas
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD009319.pub3
– volume: 23
  year: 2017
  ident: B17
  article-title: T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-Grade Gliomas: A TCGA/TCIA Project
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.Ccr-17-0560
– volume: 118
  year: 2013
  ident: B38
  article-title: Distinct IDH1/IDH2 Mutation Profiles in Purely Insular Versus Paralimbic WHO Grade II Gliomas
  publication-title: J Neurosurg
  doi: 10.3171/2012.11.Jns121100
– volume: 15
  year: 2013
  ident: B24
  article-title: Comparative Study of IDH1 Mutations in Gliomas by Immunohistochemistry and DNA Sequencing
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/not015
– volume: 30
  year: 2018
  ident: B30
  article-title: Role of Biopsies in the Management of Intracranial Gliomas
  publication-title: Prog Neurol Surg
  doi: 10.1159/000464439
– volume: 74
  year: 2019
  ident: B32
  article-title: Deep Learning can See the Unseeable: Predicting Molecular Markers From MRI of Brain Gliomas
  publication-title: Clin Radio
  doi: 10.1016/j.crad.2019.01.028
– volume: 19
  year: 2017
  ident: B34
  article-title: MRI Features Predict Survival and Molecular Markers in Diffuse Lower-Grade Gliomas
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/now256
– volume: 20
  year: 2018
  ident: B18
  article-title: The T2-FLAIR Mismatch Sign as an Imaging Marker for non-Enhancing IDH-Mutant, 1p/19q-Intact Lower-Grade Glioma: A Validation Study
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/noy048
– volume: 39
  year: 2017
  ident: B35
  article-title: Reliability of Noncontrast-Enhancing Tumor as a Biomarker of IDH1 Mutation Status in Glioblastoma
  publication-title: J Clin Neurosci
  doi: 10.1016/j.jocn.2017.01.007
– volume: 63
  year: 2021
  ident: B3
  article-title: Conventional MRI Features of Adult Diffuse Glioma Molecular Subtypes: A Systematic Review
  publication-title: Neuroradiology
  doi: 10.1007/s00234-020-02532-7
– volume: 35
  year: 2019
  ident: B16
  article-title: Value of MRI in Prediction of Glioma Isocitrate Dehydrogenase1mutation Status
  publication-title: Chin J Med Imaging Technol
  doi: 10.13929/J.1003-3289.201901063
– volume: 30
  year: 2020
  ident: B12
  article-title: Advanced Imaging Parameters Improve the Prediction of Diffuse Lower-Grade Gliomas Subtype, IDH Mutant With No 1p19q Codeletion: Added Value to the T2/FLAIR Mismatch Sign
  publication-title: Eur Radiol
  doi: 10.1007/s00330-019-06395-2
– volume: 141
  year: 2020
  ident: B36
  article-title: Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging Methods in Nonenhancing Gliomas
  publication-title: World Neurosurg
  doi: 10.1016/j.wneu.2020.05.278
– volume: 24
  year: 2014
  ident: B6
  article-title: International Society Of Neuropathology–Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
  publication-title: Brain Pathol
  doi: 10.1111/bpa.12171
– volume: 120
  start-page: 297
  year: 2010
  ident: B27
  article-title: Interobserver Variation of the Histopathological Diagnosis in Clinical Trials on Glioma: A Clinician's Perspective
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-010-0725-7
– volume: 15
  year: 2019
  ident: B31
  article-title: Multi-Parametric MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas: A Systematic Review
  publication-title: Curr Med Imaging Rev
  doi: 10.2174/1573405615666190109100503
– volume: 131
  year: 2016
  ident: B7
  article-title: The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-016-1545-1
– volume: 15
  year: 2009
  ident: B9
  article-title: IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.Ccr-09-0715
– volume: 5
  year: 2008
  ident: B20
  article-title: Technology Insight: Water Diffusion MRI–a Potential New Biomarker of Response to Cancer Therapy
  publication-title: Nat Clin Pract Oncol
  doi: 10.1038/ncponc1073
– volume: 131
  year: 2017
  ident: B37
  article-title: Prediction of Genetic Subgroups in Adult Supra Tentorial Gliomas by Pre- and Intraoperative Parameters
  publication-title: J Neurooncol
  doi: 10.1007/s11060-016-2313-8
– volume: 372
  year: 2015
  ident: B4
  article-title: Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1407279
– volume: 19
  year: 2017
  ident: B10
  article-title: Diffuse Low-Grade Glioma: A Review on the New Molecular Classification, Natural History and Current Management Strategies
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-017-1631-4
– volume: 373
  start-page: 9
  year: 2017
  ident: B13
  article-title: The Utility of Diffusion MRI With Quantitative ADC Measurements for Differentiating High-Grade From Low-Grade Cerebral Gliomas: Evidence From a Meta-Analysis
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2016.12.008
– volume: 95
  year: 2017
  ident: B23
  article-title: Histogram Analysis of Diffusion Kurtosis Imaging Estimates for In Vivo Assessment of 2016 WHO Glioma Grades: A Cross-Sectional Observational Study
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2017.08.008
– volume: 30
  year: 2019
  ident: B1
  article-title: Low-Grade Glioma Radiotherapy Treatment and Trials
  publication-title: Neurosurg Clin N Am
  doi: 10.1016/j.nec.2018.08.008
– volume: 36
  year: 2021
  ident: B33
  article-title: Relationship Between Multimodal MRI and Pathology on Diagnosis of Grade II~IV Supratentorial Glioma
  publication-title: Radiol Pract
  doi: 10.13609/j.cnki.1000-0313.2021.07.003
– volume: 51
  year: 2018
  ident: B2
  article-title: Glioma Epigenetics: From Subclassification to Novel Treatment Options
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2017.11.010
SSID ssj0000650103
Score 2.359651
Snippet Gliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI morphological characteristics,...
Background and PurposeGliomas are one of the most common tumors in the central nervous system. This study aimed to explore the correlation between MRI...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 873839
SubjectTerms apparent diffusion coefficient
diffusion-weighted magnetic resonance imaging
glioma
isocitrate dehydrogenase
magnetic resonance imaging
Oncology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JTsMwELVQD4gLYhVlk5G4cAhNE7tOjlCWglSEEEjcLK-iUpVUXfgEvpsZJ0XNBS5cYzuJPePxPHv8hpBz7QTurnUjkXgTsUyDHbSORTE3Ode5TjMdonyfeoM39vjO31dSfWFMWEUPXA1ch_ccuAgAQnIjmHIiU3nMLbwi1t4xHu6Rw5q3AqYqG8wxgUF1LgkoLO_4skDGwiS5zASgsryxDgW6_oaP2YyQXFly7rbIZu0r0qvqH7fJmit2yPqwPg3fJV_PU1dOXMXdTVVh6RNurn4qDEmnUGhH4dYCLT29H48wEogGWhBMQ7w0evR-qqybheYPNwM6XObLpQhRZzTEFNBhHXdIhy8PtN8ked4jb3e3r_1BVOdViAy4H_OIGYM3ZL1RlvHEZYZzI7j3PZ0abmGwmWHcZI55kWib2dRxoTTUy70DBGPTfdIqysIdECqEZlpZhcCEWRtnigutU9vtKgMzm7VJZznK0tSk45j7YiwBfKBcJMpFolxkJZc2ufhpMakIN36pe42C-6mHVNnhASiQrBVI_qVAbXK2FLuEqYXnJapw5WImE1jIwdvkMXRDNPSh8cVmSTH6CCTdOZi2hInD__jFI7KBvcaghUQck9Z8unAn4AvN9WlQ-2_eNwsn
  priority: 102
  providerName: Directory of Open Access Journals
Title Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics
URI https://www.proquest.com/docview/2678423504
https://pubmed.ncbi.nlm.nih.gov/PMC9196247
https://doaj.org/article/56e5220949c74ae78a905d38b0bfe457
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSFUvqLzEQqmMxIVD2qxjr51DhaDQ3SKlQoiV9mb5WVZaJZDdIvoH-N3MONlCpIoDlxwSjyJ7PJ757PE3hLyyQeLu2jiTLLqMKwvroA88y4UrhS1toWzK8r2YzOb840Is_lyP7gdwfSu0w3pS83Z19PP79Rsw-BNEnOBvj2NTIxkhY0dKAuAq75J74Jck1jOo-mC_W5cFFjXozipvFdwju4WQ4PFUMXBTic1_EIIOEyj_8khn--R-H0rSt53uH5A7oX5Idqv-sPwR-fWpDdCZjtqbmtrTC9x7_WEwY53CR79MlxpoE-l0tcREIZpYQ7BK8XZNpNPW-LBO4ufvZ7TaltOliGDXNKUc0KpPS6TV53N6OuSAfkzmZx--nM6yvuxC5iA62WTcObxAG53xXLCgnBBOihgntnDCM5Zzx4VTgUfJrFe-CEIaC-3KGADg-OIJ2ambOjwlVErLrfEGcQv3PldGSGsLPx4bB4bPR-R4O8ra9ZzkWBpjpQGboIo0qkijinSnohF5fSPxrePj-Efbd6i4m3bIpJ1eNO2l7g1Ti0mAEBRAbukkN0EqU-bCwxTNbQxcyBF5uVW7BsvD4xRTh-ZqrRn4eQhGRQ7dkIP5MPjj8Eu9_Jo4vEtY-RiXz_5b8jnZw65iIgOTB2Rn016FFxAfbexh2leA53QxPkwm8BuhxhXr
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preoperative+and+Noninvasive+Prediction+of+Gliomas+Histopathological+Grades+and+IDH+Molecular+Types+Using+Multiple+MRI+Characteristics&rft.jtitle=Frontiers+in+oncology&rft.au=Du%2C+Ningfang&rft.au=Zhou%2C+Xiaotao&rft.au=Mao%2C+Renling&rft.au=Shu%2C+Weiquan&rft.date=2022-05-27&rft.pub=Frontiers+Media+S.A&rft.eissn=2234-943X&rft.volume=12&rft_id=info:doi/10.3389%2Ffonc.2022.873839&rft_id=info%3Apmid%2F35712483&rft.externalDocID=PMC9196247
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon